|
Enterprise "Strategic Directions for Therapeutic Vaccines Research" Webinar
Mon, Nov 18, 2013 at 12:00 PM EST
Meeting Description:
The therapeutic HIV vaccine field has seen a revival in the recent years, largely associated with the cure agenda. The Enterprise,
together with AVAC, the Treatment Action Group, and the Bill & Melinda Gates Foundation, organized a meeting to discuss the
state of the field and to provide strategic recommendations for future developments.
The meeting took place on September 19-20 in Bethesda, Maryland. To learn more about the meeting, visit
http://www.vaccineenterprise.org/content/timely-topic-therapeutic-vaccines
The webinar will update on the issues discussed at the meeting, including:
- scientific gaps in therapeutic vaccine development;
- opportunities for scientific coordination and synergies between the areas of therapeutic vaccine, preventive vaccine, the treatment optimization, and cure research;
- and ethical and regulatory considerations related to trial design, including choice of clinical endpoints.
Details:
Date: Mon, Nov 18, 2013
Time: 12:00 PM EST
Duration: 1 hour
Host(s): Yegor Voronin
Presenter Information:
Jose Esparza
Senior Advisor, Vaccines
Bill & Melinda Gates Foundation, USA
Richard Jefferys
Basic Science, Vaccines, and Prevention Project Coordinator
Treatment Action Group (TAG), USA
Janet Siliciano
Associate Professor
The Johns Hopkins School of Medicine, USA
Genoveffa Franchini
Senior Investigator
National Cancer Institute, USA
###
Register for the Webinar
To access the webinar, please register here: https://cc.readytalk.com/cc/s/registrations/new?cid=68wm0ch6bj72.
Contacts:
Jennifer Brunet
+1 (212) 461-3693
jbrunet@vaccineenterprise.org
About the Global HIV Vaccine Enterprise
The Global HIV Vaccine Enterprise is a unique alliance of independent research organizations, funders and advocates dedicated to
accelerating the development of safe and effective HIV vaccines. Enterprise stakeholders are the global leaders in HIV vaccine
research: the African AIDS Vaccine Partnership, the Global Advocacy for HIV Prevention (AVAC), AIDS Vaccine for Asia Network,
The Bill & Melinda Gates Foundation, European Commission, GlaxoSmithKline, Government of Canada, the International AIDS
Vaccine Initiative (IAVI), the Medical Research Council, Merck, National Agency for research on AIDS and Viral Hepatitis
in France (ANRS), Novartis, sanofi pasteur, the U.S. National Institutes of Health, U.S. Agency for International
Development (USAID), U.S. Military HIV Research Program, Joint United Nations Programme on HIV/AIDS (UNAIDS),
Wellcome Trust and World Health Organization.
Contacts
Jennifer Brunet
+1 (212) 461-3693
jbrunet@vaccineenterprise.org
"Reproduced with permission - Global HIV Vaccine Enterprise"
Global HIV Vaccine Enterprise
For more HIV and AIDS News visit...
Positively Positive - Living with HIV/AIDS:
HIV/AIDS News
|
